XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement of Assets and Liabilities (Tables)
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of June 30, 2020 (in thousands):
Balance as of
June 30, 2020
Level 1
Assets:
Cash equivalents
Money market funds$126  $126  
Total cash equivalents$126  $126  

Balance as of
June 30, 2020
Level 3
Liabilities:
2025 Notes
Interest make-whole payment$3,756  $3,756  
Total embedded derivatives$3,756  $3,756  
The following table summarizes the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of December 31, 2019 (in thousands):
Balance as of
December 31, 2019
Level 1
Assets:
Cash equivalents
Money market funds$126  $126  
Total cash equivalents$126  $126  
Schedule of Fair Value Valuation Model and Assumptions
The fair value of the interest make-whole payment derivative liability was determined using a binomial lattice model with the following key assumptions:
May 12, 2020June 30, 2020
Volatility60 %60 %
Stock price as of June 30, 2020$10.62 per share$11.60 per share
Credit spread14.97 %12.47 %
Term4.97 years4.84 years
Dividend yield— %— %
Risk-free rate0.34 %0.28 %
Summary of Changes in Fair Value of Level 3 Liabilities
The following table sets forth a summary of changes in the fair value of Level 3 liabilities for the six months ended June 30, 2020 (in thousands):
Balance as of
December 31, 2019
AdditionsChange in fair valueBalance as of
June 30, 2020
Liabilities:
Interest make-whole payment$—  $4,582  $(826) $3,756